Assignee
BEREN THERAPEUTICS P B C
US·6 granted patents·11 pending applications·15 citations·filing 2021–2025
Top patents by PatentIndex Score
17 records- 0193US11958917B2Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the sameBEREN THERAPEUTICS P B C·Filed 2023·Granted Apr 16, 2024·12 cites·33 claims
- 0291US12215174B2Compositions of hydroxypropyl-β-cyclodextrin and methods of purifying the sameBEREN THERAPEUTICS P B C·Filed 2024·Granted Feb 4, 2025·2 cites·28 claims
- 0390US12168701B2Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the sameBEREN THERAPEUTICS P B C·Filed 2023·Granted Dec 17, 2024·1 cites·13 claims
- 0489US12534542B2Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the sameBEREN THERAPEUTICS P B C·Filed 2024·Granted Jan 27, 2026·0 cites·22 claims
- 0587US12509531B2Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the sameBEREN THERAPEUTICS P B C·Filed 2024·Granted Dec 30, 2025·0 cites·16 claims
- 0686US2026015437A1Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the sameBEREN THERAPEUTICS P B C·Filed 2025·Application pending·0 cites
- 0785US12258426B2Compositions of hydroxypropyl-beta-cyclodextrin and methods of purifying the sameBEREN THERAPEUTICS P B C·Filed 2024·Granted Mar 25, 2025·0 cites·19 claims
- 0872US2023375576A1Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrinsBEREN THERAPEUTICS P B C·Filed 2023·Application pending·0 cites
- 0966US2022260597A1Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrinsBEREN THERAPEUTICS P B C·Filed 2022·Application pending·0 cites
- 1066US2023091966A1Methods for the treatment of cardiovascular disease with cyclodextrinsBEREN THERAPEUTICS P B C·Filed 2022·Application pending·0 cites
- 1164US2026028655A1Methods for producing beta-cyclodextrinsBEREN THERAPEUTICS P B C·Filed 2023·Application pending·0 cites
- 1264US2024398849A1Methods for the treatment of hypertriglyceridemia with cyclodextrinsBEREN THERAPEUTICS P B C·Filed 2024·Application pending·0 cites
- 1364US2026062727A1Methods for producing gamma-cyclodextrinsBEREN THERAPEUTICS P B C·Filed 2023·Application pending·0 cites
- 1463US2024000826A1Methods for the treatment of cardiovascular disease with cyclodextrinsBEREN THERAPEUTICS P B C·Filed 2021·Application pending·0 cites
- 1562US2026041704A1Compositions and methods for treating sickle cell diseaseBEREN THERAPEUTICS P B C·Filed 2023·Application pending·0 cites
- 1655US2023330133A1Methods for the treatment of cholesterol crystal embolization with cyclodextrinsBEREN THERAPEUTICS P B C·Filed 2021·Application pending·0 cites
- 1755US2023302042A1Methods for the prevention of cholesterol crystal embolization with cyclodextrinsBEREN THERAPEUTICS P B C·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when BEREN THERAPEUTICS P B C files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →